A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with rVWF in Children Diagnosed with Severe Von Willebrand Disease ( rVWF Pediatric Prophylaxis Study) (TAK-577-3001)

Principal Investigator

Dr Saket Badle

Contact us

Email: Ashley.Yburan@ouh.nhs.uk

IRAS number

1012981